JHM Biopharma Secures Over USD 28 Million in Series B+ Financing to Boost Pipeline Development
JHM Biopharma, a protein drug developer based in Hangzhou, has reportedly secured over RMB 200...
JHM Biopharma
JHM Biopharma Raises RMB100 Million to Expand Protein Drug Pipeline
Hangzhou-based protein drug developer JHM Biopharma has reportedly secured close to RMB100 million (USD14.9 million)...